New Biotech Pair Trade: Infinity Pharma Over ImmunoGen

By: via Benzinga
Infinity Pharmaceuticals Inc (NASDAQ: INFI) shares are down nearly 45 percent year-to-date, while Immunogen, Inc (NASDAQ: IMGN) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.